Zeniva® PEEK offers clear imaging and bone-like flexibility for unique implantable fracture plates
Syensqo, previously part of Solvay Group and a leading global provider of advanced performance materials and chemical solutions, is making its debut at Compamed 2024. Visitors will be able to explore the company’s full range of high-performance polymers for the healthcare and pharmaceuticals industry, including an advanced portfolio of Solviva® biomaterials for implantable medical devices.
We are very pleased to present our complete materials offering to the medical and pharmaceutical audience at Compamed. The applications shown at our booth benefit from our long-standing experience in this demanding market and demonstrate the capabilities of our teams to help customers turn their innovative concepts to reality.
One of the highlights on display will be the novel implantable ApolloAnkle™ Fracture Plating System (Apollo AFX) by GLW Medical Innovation, featuring a wide selection of hybrid plates that combine a 3D-printed titanium shell with injection molded Zeniva® polyetherether ketone (PEEK). All plates are manufactured in a proprietary zero-waste process and exhibit smooth, rounded corners to minimize the risk of soft tissue irritation. GLW’s patented PEEKLOC™ technology complements the system to permit polyaxial screw placement over a total range of 30 degrees. The hybrid plate interface minimizes the risk of plate and screw ‘cold-welding’ that has been seen with incumbent systems.
We are elevating the plating market through our 3D-printed Ti-PEEK hybrid plating platform. Apollo AFX represents a game-changing technology by delivering a clinically differentiated, compliant and cost-effective solution to the orthopedic landscape. As in previous projects, Zeniva® PEEK provided exactly the right property profile to enable this unique innovation.
Zeniva® PEEK is one of the most bio-stable plastics available and meets the requirements of ASTM F2026-07 for implantable applications in human surgery. It can be carbon reinforced and delivers high strength, stiffness, toughness and fatigue resistance. These attributes and a modulus of elasticity similar to that of cortical bone greatly support the stress shielding protection provided by the Apollo AFX system.
In contrast to traditional metal, the PEEK polymer also offers greater design freedom for complex anatomical contouring of implants. Its natural ortholucency improves the intraoperative and postoperative visualization of bones and joint spaces in medical imaging.
Syensqo will exhibit during Compamed 2024 from November 11 to 14 in Düsseldorf, Germany, at Booth L14 in Hall 8a.
Zeniva® is a registered trademark of Syensqo.
ApolloAnkle ™ and PEEKLOC™ are trademarks of GLW, Inc.
Syensqo is a science company developing groundbreaking solutions that enhance the way we live, work, travel and play. Inspired by the scientific councils which Ernest Solvay initiated in 1911, we bring great minds together to push the limits of science and innovation for the benefit of our customers, with a diverse, global team of more than 13,000 associates in 30 countries.
Our solutions contribute to safer, cleaner, and more sustainable products found in homes, food and consumer goods, planes, cars, batteries, smart devices and healthcare applications. Our innovation power enables us to deliver on the ambition of a circular economy and explore breakthrough technologies that advance humanity.
Learn more at www.syensqo.com.
GLW is a medical technology company that uses its proprietary ortholucent technology platform to develop, additive manufacture, and sell orthopedic extremity and trauma implants and instruments. GLW owns issued patents and pending patent applications that cover hybrid materials and cost-effective manufacturing.
Visit glwmed.com for further information.
Downloads
Implantable Devices
Syensqo formulates Solviva® Biomaterials, a family of specialty polymers, to meet the industry demand for metal alternatives that provide optimal performance and meet the requirements for prolonged or permanent exposure to bodily fluids and tissue in the human body.